DK0852469T3 - Anvendelse af threonin til behandling af phenylketonuri - Google Patents

Anvendelse af threonin til behandling af phenylketonuri

Info

Publication number
DK0852469T3
DK0852469T3 DK96932564T DK96932564T DK0852469T3 DK 0852469 T3 DK0852469 T3 DK 0852469T3 DK 96932564 T DK96932564 T DK 96932564T DK 96932564 T DK96932564 T DK 96932564T DK 0852469 T3 DK0852469 T3 DK 0852469T3
Authority
DK
Denmark
Prior art keywords
threonine
phenylketonuria
treatment
composition
foods
Prior art date
Application number
DK96932564T
Other languages
Danish (da)
English (en)
Inventor
Gilda Georgi
Guenther Sawatzki
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK0852469T3 publication Critical patent/DK0852469T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96932564T 1995-09-18 1996-09-18 Anvendelse af threonin til behandling af phenylketonuri DK0852469T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19534602A DE19534602C2 (de) 1995-09-18 1995-09-18 Verwendung von Threonin zur Behandlung der Phenylketonurie
PCT/EP1996/004093 WO1997012527A2 (fr) 1995-09-18 1996-09-18 Utilisation de la threonine pour le traitement de la phenylcetonurie

Publications (1)

Publication Number Publication Date
DK0852469T3 true DK0852469T3 (da) 2002-05-13

Family

ID=7772491

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96932564T DK0852469T3 (da) 1995-09-18 1996-09-18 Anvendelse af threonin til behandling af phenylketonuri

Country Status (10)

Country Link
US (1) US20010011070A1 (fr)
EP (1) EP0852469B1 (fr)
JP (1) JP2000502323A (fr)
AT (1) ATE209005T1 (fr)
CA (1) CA2232134A1 (fr)
DE (2) DE19534602C2 (fr)
DK (1) DK0852469T3 (fr)
ES (1) ES2168508T3 (fr)
PT (1) PT852469E (fr)
WO (1) WO1997012527A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
US20100317562A1 (en) * 2007-03-23 2010-12-16 Lynn Paolella Dietary Compositions
EP2008656A1 (fr) 2007-06-28 2008-12-31 Bergen Teknologioverforing AS Compositions pour le traitement d'hyperphénylalaninémie
FR3002831B1 (fr) * 2013-03-11 2015-07-17 Lactalis Nutrition Sante Produit alimentaire pret a consommer pour patients atteints d'une maladie du metabolisme d'un ou de plusieurs acides amines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122508A (en) * 1965-07-16 1968-08-07 Kyowa Hakko Kogyo Kk Process for producing l-threonine
DE2654820C3 (de) * 1976-12-03 1986-07-31 Maizena Gmbh, 2000 Hamburg Aminosäuregemisch
FR2505144B1 (fr) * 1981-05-11 1985-10-25 Fabre Sa Pierre Association edulcorante exempte de sucre et son procede de preparation
JPS595111A (ja) * 1982-07-02 1984-01-12 Meiji Milk Prod Co Ltd フエニ−ルケトン尿症乳幼児用栄養調製物
IT1212792B (it) * 1983-11-30 1989-11-30 Egidio Aldo Moja Supplemento dietetico e alimento preconfezionato che lo contiene procedimento di preparazione e metodo di somministrazione
DD226775A1 (de) * 1984-08-29 1985-09-04 Berlin Chemie Veb Verfahren zur herstellung eines diaetetischen praeparats
DD294865A5 (de) * 1990-06-07 1991-10-17 Veb Berlin-Chemie,De Phenylalaninfreies aminosaeuregemisch mit organoleptisch guten eigenschaften zur ernaehrung von phenylketonurie-patienten
DE4037447C2 (de) * 1990-11-24 1994-06-01 Milupa Ag Phenylalaninfreies Diätetikum für juvenile und adulte Personen mit Phenylketonurie sowie ein Verfahren zu seiner Herstellung
DE4042115C2 (de) * 1990-12-28 1993-11-25 Milupa Ag Phenylalaninfreie Säuglings- und Kleinkindernahrungsgrundlage und Verfahren zu ihrer Herstellung
ES2087027B1 (es) * 1994-08-03 1997-02-01 Univ Illes Balears Suplementos nutricionales termogeneticos, alimentos que los contienen y aplicaciones.

Also Published As

Publication number Publication date
US20010011070A1 (en) 2001-08-02
JP2000502323A (ja) 2000-02-29
DE19534602A1 (de) 1997-04-10
WO1997012527A2 (fr) 1997-04-10
PT852469E (pt) 2002-03-28
WO1997012527A3 (fr) 1997-05-01
EP0852469B1 (fr) 2001-11-21
DE59608276D1 (de) 2002-01-03
EP0852469A2 (fr) 1998-07-15
ATE209005T1 (de) 2001-12-15
ES2168508T3 (es) 2002-06-16
DE19534602C2 (de) 1999-09-09
CA2232134A1 (fr) 1997-04-10

Similar Documents

Publication Publication Date Title
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
FR2754820B1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
BG101118A (en) Therapeutical compounds
MXPA04005376A (es) Composiciones farmaceuticas y sus usos.
TW264480B (fr)
AU687909B2 (en) Protein kinase C inhibitors
IL108007A (en) USE OF AN INTERFERON-GAMMA (IFN-gamma) INHIBITOR IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
EP0705100A4 (fr) Guanidines substituees therapeutiques
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
GB2288732B (en) Pharmaceutical compositions
EP0301570A3 (fr) Oligopeptides utiles pour le traitement du SIDA
ZA945425B (en) 2-amino-4-phenyl-4-oxo-butyric acid derivatives
JO1696B1 (en) Acetamide derivatives
BG102106A (en) Phermaceutical composition containing proteinase inhibitor and monoglyceride
WO1996022305A3 (fr) Peptides modifies
DK0852469T3 (da) Anvendelse af threonin til behandling af phenylketonuri
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
EE9600109A (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
DE69726602D1 (en) Hepatitis b inhibitoren
AU6970394A (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
BG104452A (en) New derivatives of the methylenebisphosphonic acid
GR3035004T3 (en) Method and composition for the treatment of herpes related disorders.
EA199600048A2 (ru) N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции